With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Optimizing Engager T-cells for CD19+ Malignancies||Baylor College of Medicine / Mireya Paulina Velasquez, MD||Young Investigator Grants||2014||Texas|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma||Lucile Packard Children's Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD||Young Investigator Grants||2014||California|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL||New York University School of Medicine / Mate Maus, PhD||Young Investigator Grants||2014||New York|
|SETD2 Mutations in Prognosis and Chemotherapy Resistance in Relapsed Acute Lymphoblastic Leukemia||Dana-Farber Cancer Institute / Brenton Mar, MD, PhD||Young Investigator Grants||2014||Massachusetts|
|Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells||Dana-Farber Cancer Institute / Zhaodong Li, PhD||Young Investigator Grants||2014||Massachusetts|
|Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma||University of Michigan / Carl Koschmann, MD||Young Investigator Grants||2014||Michigan|
|Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma||University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD||Young Investigator Grants||2014||Hawaii|
|A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell||The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD||Young Investigator Grants||2014||Maryland|